Skip to main content
MS relapse rates similar between anti-CD20 mAbs and switching to fumarates
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
MS relapse rates similar between anti-CD20 mAbs and switching to fumarates
User login
Username
Password
Reset your password
Concept
Lead
score
Multiple Sclerosis
1
1
Inpatient Care
0
0.69
Monoclonal Antibody
0
0.55
Multiple Sclerosis Relapse
0
0.41
Biologic Therapy
0
0.32
Sepsis
0
0.16
Antineoplastic Drug
0
0.14
Chronic Disease
0
0.14
Corticosteroids
0
0.14
Disease-Modifying Therapy
0
0.14
Escherichia coli
0
0.14
Health Care Cost
0
0.14
Intravenous
0
0.14
New York
0
0.14
Plasma
0
0.14
Steroids
0
0.14
Pneumonia
0
0.13
COVID-19
0
0.08
Erectile Dysfunction
0
0.08
Urinary Tract Infection
0
0.08
Specialty
Lead
score
Neurology & Neurosurgery
1
1
Internal Medicine
0
1
Hospital Medicine
0
0.56
Family Medicine/Primary Care
0
0.5
Infectious Diseases
0
0.44
Pharmacist
0
0.32
Critical Care
0
0.25
Pulmonary Medicine
0
0.2
Urology
0
0.16
Hematology-Oncology
0
0.14
Public Health & Prevention
0
0.14
Gastroenterology
0
0.08
Nursing
0
0.08
Edit Tags